Webinars

How to de-identify (almost) anything

Join this webinar to explore how leading organizations are expanding their understanding and approaches to broadening data types to enable innovation.

Transparency-by-Design: Build Efficiencies into Your Clinical Document Disclosure Process

Join Abby McDonell, Sr. Program Manager with IQVIA’s Clinical Trial Transparency Team (powered by Privacy Analytics), to gain actionable insights on optimising your medical writing processes to ...

10 Best Practices for ROI on HIPAA Expert Determination

In this webinar, we’ll explore 10 non-technical best practices for HIPAA Expert Determination aimed at reducing timelines, rework, and costs while maximizing the organizational benefit from the data ...

Linkage, Tokenization and De-identification

Watch this replay of our webinar to learn about tokenization and how it can be used to match individuals without exposing key identifiers, the risk of re-identification and how it can increase when ...

CASE STUDY Navigating a First-Time Health Canada PRCI Submission: Learnings and Perspectives from Argenx and Privacy Analytics

Watch this replay of our presentation at Informa Connect’s Clinical Data Disclosure, Transparency and Plain Language Summaries U.S. Conference and hear some perspectives on collaborative best ...

Using Technology to Streamline the Publication of Anonymized Clinical Trial Documents and Protect CCI

Watch this replay of our presentation at Informa's Clinical Data Disclosure Europe event to hear about solutions to some of the common challenges in clinical trial document and data disclosure.

Everything You Need to Know About EMA Policy 0070 Right Now

On May 16, the European Medicines Agency (EMA) confirmed that after a long hiatus (punctuated only by COVID-related publications), Policy 0070 will officially resume in September 2023. Join Niamh ...

Safely Accelerate Clinical Document Submissions While Protecting Commercially Confidential Information (CCI)

As a clinical trial sponsor, you’re under tight timelines to balance participant privacy and data utility in clinical document submissions while justifying and protecting commercially sensitive ...

How to Protect Your Company’s Commercial Interest Under EU CTR

As a clinical trial sponsor, you’re under pressure to be transparent, but how do you ensure your clinical study documents don’t reveal confidential trade secrets when published by regulators?

3 Ways to Safely Accelerate Your Clinical Document Submissions

As a clinical trial sponsor, you were already facing tight timelines and resource constraints in handling regulatory requirements for document anonymization and redaction.

Filter by Data Type

Categories